Struthers Richard Scott's Form 4 filing
Crinetics Pharmaceuticals, Inc. (CRNX) · filed Jul 13, 2023
- Accession no.
- 0001209191-23-042229
- Filed
- Jul 13, 2023
- Trade date
- Jul 11-13, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Checked
This filing lists 3 non-derivative transactions. Open-market sales total $1.01M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Struthers Richard ScottCIK 0001746298 | Director, Officer (President & CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Jul 11, 2023 | Common Stock | SSaleDisposed | −24,384 | $20.14F1 | −$491,093.76 | 656,421 | Indirect | |
| Jul 12, 2023 | Common Stock | SSaleDisposed | −11,459 | $20.17F2 | −$231,128.03 | 644,962 | Indirect | |
| Jul 13, 2023 | Common Stock | SSaleDisposed | −14,157 | $20.35F3 | −$288,094.95 | 630,805 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $20.14 per share. The range of sales prices on the transaction date was $20.10 to $20.25 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request
Referenced by the price of 1 transaction in Table I.
- F2
The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $20.17 per share. The range of sales prices on the transaction date was $20.10 to $20.31 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
Referenced by the price of 1 transaction in Table I.
- F3
The common stock was sold by the reporting person in open market transactions on the transaction date, with a weighted average sales price of $20.35 per share. The range of sales prices on the transaction date was $20.10 to $20.68 per share. Detailed information on the exact number of shares can be obtained from the issuer upon request.
Referenced by the price of 1 transaction in Table I.